Holding(s) in Company
RNS Number : 3571K Condor Gold PLC 20 September 2016
| Condor Gold plc 7thFloor 39 St.James'sStreet London SW1A 1JD Telephone +4402074081067Fax:+4402074938633 |
| Condor Gold plc | Mark Child, Executive Chairman and CEO +44 (0) 20 7493 2784 |
| Beaumont Cornish Limited Numis Securities Limited | Roland Cornish and James Biddle +44 (0) 20 7628 3396 John Prior and James Black +44 (0) 20 72601000 |
| Farm Street Media | Simon Robinson +44 (0) 7593 340107 |
| TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | ||||
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:ii | Condor Gold plc | |||
| 2 Reason for the notification (please tick the appropriate box or boxes): | ||||
| An acquisition or disposal of voting rights | N/A | |||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | N/A | |||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | N/A | |||
| An event changing the breakdown of voting rights | N/A | |||
| Other (please specify): | Involuntary dilution | Yes | ||
| 3. Full name of person(s) subject to the notification obligation:iii | Regent Pacific Group Limited | |||
| 4. Full name of shareholder(s) (if different from 3.):iv | Regent Pacific Group Limited | |||
| 5. Date of the transaction and date on which the threshold is crossed or reached:v | The holding of Regent Pacific Group Limited in CNR was diluted upon the issue and allotment of new shares by CNR on 19 September 2016 pursuant to the conversion of warrants. | |||
| 6. Date on which issuer notified: | 19 September 2016 | |||
| 7. Threshold(s) that is/are crossed or reached: vi, vii | 8% | |||
| 8. Notified details: | ||||||||||||||||
| A: Voting rights attached to sharesviii, ix | ||||||||||||||||
| Class/type of shares if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | ||||||||||||||
| Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights x | ||||||||||||
| Direct | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
| Ordinary shares | 3,977,274 | 3,977,274 | 3,977,274 | 3,977,274 | Nil | 7.517% | Nil | |||||||||
| B: Qualifying Financial Instruments | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument | Expiration date xiii | Exercise/ Conversion Period xiv | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights | ||||||||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
| Resulting situation after the triggering transaction | ||||||||||||||||
| Type of financial instrument | Exercise price | Expiration date xvii | Exercise/ Conversion period xviii | Number of voting rights instrument refers to | % of voting rights xix, xx | |||||||||||
| Nominal | Delta | |||||||||||||||
| Total (A+B+C) | ||||||||||||||||
| Number of voting rights | Percentage of voting rights | |||||||||||||||
| 3,977,274 | 7.517% | |||||||||||||||
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi | ||
| Proxy Voting: | ||
| 10. Name of the proxy holder: | N/A | |
| 11. Number of voting rights proxy holder will cease to hold: | N/A | |
| 12. Date on which proxy holder will cease to hold voting rights: | N/A | |
13. Additional information: | N/A | |
| 14. Contact name: | Stella Fung | |
| 15. Contact telephone number: | +852 2514 6111 | |
Recent news on Regent Pacific
See all newsBrief: Regent Pacific Says SenstendTM Approved By NMPA For Premature Ejaculation In China
Brief: Regent Pacific Says Deep Longevity To Launch U.S. Expansion In Q1 2026
Brief: Regent Pacific Shall Allot And Issue 63.4 Million Shares At Hk$0.485 Per Share
Brief: Regent Pacific Announces Submission Of Senstend New Drug Application To NMPA In China
Brief: Regent Pacific Enters Manufacturing And Supply Agreement For SENSTEND